COVID-19 Patients Having Sufficient Vitamin D Experience Reduced Complications and Lower Mortality
2 min read
very difficult
A study has found that hospitalized COVID-19 patients who were vitamin D sufficient had a significant decreased risk for adverse clinical outcomes and lower blood levels of an inflammatory marker (C-reactive protein), as well as higher blood levels of lymphocytes (a type of immune cell to help fight infection).
In a study by researchers from the Boston University School of Medicine (Boston, MA, USA), a blood sample to measure vitamin D status (measured serum level of 25-hydroxyvitamin D) was taken from 235 patients were admitted to the hospital with COVID-19. These patients were followed for clinical outcomes, including clinical severity of the infection, becoming unconscious, having difficulty in breathing resulting in hypoxia and death. The blood was also analyzed for C-reactive protein and for numbers of lymphocytes. The researchers then compared all of these parameters in patients who were vitamin D deficient to those who were vitamin D sufficient. In patients older than 40 years they observed that those patients who were vitamin D sufficient were 51.5% less likely to die from the infection…
HospiMedica International
Read full article